Predicción y previsión de precio de Can Fite Biopharma Ltd (CANF)CANFCan Fite Biopharma Ltd

Alphio's CANF stock price prediction model matches the current Can Fite Biopharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.63 (+0.37%). The 1-week path is $1.55 (-4.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Can Fite Biopharma Ltd (CANF) is not a good buy. The stock is trading at $1.62, significantly down from its 52-week high of $12.30, which reflects a staggering 80.18% decline over the past year. The RSI is at 34.499, indicating that the stock is oversold, but the forward P/E ratio is 2.9665, suggesting that the stock may still be undervalued. However, the company continues to report substantial net losses, with a net income of -2,300,500 USD in Q2 2026. The main risk is the ongoing operating losses and the negative sentiment reflected in the 20-day change of -14.74%.

Can Fite Biopharma Ltd (CANF) last closed at $1.62, gaining +1.25%. These facts feed the 1-day and 1-week CANF price prediction above.